Effect of image registration on 3D absorbed dose calculations in 177Lu-DOTATOC peptide receptor radionuclide therapy

Elisa Grassi, Federica Fioroni, Salvatore Berenato, Nick Patterson, Valentina Ferri, Luca Braglia, Angelina Filice, Annibale Versari, Mauro Iori, Emiliano Spezi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Peptide receptor radionuclide therapy (PRRT) is an effective MRT (molecular radiotherapy) treatment, which consists of multiple administrations of a radiopharmaceutical labelled with 177Lu or 90Y. Through sequential functional imaging a patient specific 3D dosimetry can be derived. Multiple scans should be previously co-registered to allow accurate absorbed dose calculations. The purpose of this study is to evaluate the impact of image registration algorithms on 3D absorbed dose calculation. A cohort of patients was extracted from the database of a clinical trial in PRRT. They were administered with a single administration of 177Lu-DOTATOC. All patients underwent 5 SPECT/CT sequential scans at 1 h, 4 h, 24 h, 40 h, 70 h post-injection that were subsequently registered using rigid and deformable algorithms. A similarity index was calculated to compare rigid and deformable registration algorithms. 3D absorbed dose calculation was carried out with the Raydose Monte Carlo code. The similarity analysis demonstrated the superiority of the deformable registrations (p <.001). Average absorbed dose to the kidneys calculated using rigid image registration was consistently lower than the average absorbed dose calculated using the deformable algorithm (90% of cases), with percentage differences in the range [−19; +4]%. Absorbed dose to lesions were also consistently lower (90% of cases) when calculated with rigid image registration with absorbed dose differences in the range [−67.2; 100.7]%. Deformable image registration had a significant role in calculating 3D absorbed dose to organs or lesions with volumes smaller than 100 mL. Image based 3D dosimetry for 177Lu-DOTATOC PRRT is significantly affected by the type of algorithm used to register sequential SPECT/CT scans.

Original languageEnglish
Pages (from-to)177-185
Number of pages9
JournalPhysica Medica
Volume45
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Peptide Receptors
Radioisotopes
radioactive isotopes
peptides
therapy
dosage
Therapeutics
Radiopharmaceuticals
lesions
dosimeters
Radiotherapy
DOTA(0)-Tyr(3)-177lu-octreotide
Clinical Trials
Databases
registers
kidneys
Kidney
Injections
organs
radiation therapy

Keywords

  • Deformable image registration
  • Dose calculation
  • Dosimetry
  • PRRT

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging
  • Physics and Astronomy(all)

Cite this

Effect of image registration on 3D absorbed dose calculations in 177Lu-DOTATOC peptide receptor radionuclide therapy. / Grassi, Elisa; Fioroni, Federica; Berenato, Salvatore; Patterson, Nick; Ferri, Valentina; Braglia, Luca; Filice, Angelina; Versari, Annibale; Iori, Mauro; Spezi, Emiliano.

In: Physica Medica, Vol. 45, 01.01.2018, p. 177-185.

Research output: Contribution to journalArticle

Grassi, Elisa ; Fioroni, Federica ; Berenato, Salvatore ; Patterson, Nick ; Ferri, Valentina ; Braglia, Luca ; Filice, Angelina ; Versari, Annibale ; Iori, Mauro ; Spezi, Emiliano. / Effect of image registration on 3D absorbed dose calculations in 177Lu-DOTATOC peptide receptor radionuclide therapy. In: Physica Medica. 2018 ; Vol. 45. pp. 177-185.
@article{02c230a986d0444dbe9572b0c803ce6f,
title = "Effect of image registration on 3D absorbed dose calculations in 177Lu-DOTATOC peptide receptor radionuclide therapy",
abstract = "Peptide receptor radionuclide therapy (PRRT) is an effective MRT (molecular radiotherapy) treatment, which consists of multiple administrations of a radiopharmaceutical labelled with 177Lu or 90Y. Through sequential functional imaging a patient specific 3D dosimetry can be derived. Multiple scans should be previously co-registered to allow accurate absorbed dose calculations. The purpose of this study is to evaluate the impact of image registration algorithms on 3D absorbed dose calculation. A cohort of patients was extracted from the database of a clinical trial in PRRT. They were administered with a single administration of 177Lu-DOTATOC. All patients underwent 5 SPECT/CT sequential scans at 1 h, 4 h, 24 h, 40 h, 70 h post-injection that were subsequently registered using rigid and deformable algorithms. A similarity index was calculated to compare rigid and deformable registration algorithms. 3D absorbed dose calculation was carried out with the Raydose Monte Carlo code. The similarity analysis demonstrated the superiority of the deformable registrations (p <.001). Average absorbed dose to the kidneys calculated using rigid image registration was consistently lower than the average absorbed dose calculated using the deformable algorithm (90{\%} of cases), with percentage differences in the range [−19; +4]{\%}. Absorbed dose to lesions were also consistently lower (90{\%} of cases) when calculated with rigid image registration with absorbed dose differences in the range [−67.2; 100.7]{\%}. Deformable image registration had a significant role in calculating 3D absorbed dose to organs or lesions with volumes smaller than 100 mL. Image based 3D dosimetry for 177Lu-DOTATOC PRRT is significantly affected by the type of algorithm used to register sequential SPECT/CT scans.",
keywords = "Deformable image registration, Dose calculation, Dosimetry, PRRT",
author = "Elisa Grassi and Federica Fioroni and Salvatore Berenato and Nick Patterson and Valentina Ferri and Luca Braglia and Angelina Filice and Annibale Versari and Mauro Iori and Emiliano Spezi",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.ejmp.2017.11.021",
language = "English",
volume = "45",
pages = "177--185",
journal = "Physica Medica",
issn = "1120-1797",
publisher = "Associazione Italiana di Fisica Medica",

}

TY - JOUR

T1 - Effect of image registration on 3D absorbed dose calculations in 177Lu-DOTATOC peptide receptor radionuclide therapy

AU - Grassi, Elisa

AU - Fioroni, Federica

AU - Berenato, Salvatore

AU - Patterson, Nick

AU - Ferri, Valentina

AU - Braglia, Luca

AU - Filice, Angelina

AU - Versari, Annibale

AU - Iori, Mauro

AU - Spezi, Emiliano

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Peptide receptor radionuclide therapy (PRRT) is an effective MRT (molecular radiotherapy) treatment, which consists of multiple administrations of a radiopharmaceutical labelled with 177Lu or 90Y. Through sequential functional imaging a patient specific 3D dosimetry can be derived. Multiple scans should be previously co-registered to allow accurate absorbed dose calculations. The purpose of this study is to evaluate the impact of image registration algorithms on 3D absorbed dose calculation. A cohort of patients was extracted from the database of a clinical trial in PRRT. They were administered with a single administration of 177Lu-DOTATOC. All patients underwent 5 SPECT/CT sequential scans at 1 h, 4 h, 24 h, 40 h, 70 h post-injection that were subsequently registered using rigid and deformable algorithms. A similarity index was calculated to compare rigid and deformable registration algorithms. 3D absorbed dose calculation was carried out with the Raydose Monte Carlo code. The similarity analysis demonstrated the superiority of the deformable registrations (p <.001). Average absorbed dose to the kidneys calculated using rigid image registration was consistently lower than the average absorbed dose calculated using the deformable algorithm (90% of cases), with percentage differences in the range [−19; +4]%. Absorbed dose to lesions were also consistently lower (90% of cases) when calculated with rigid image registration with absorbed dose differences in the range [−67.2; 100.7]%. Deformable image registration had a significant role in calculating 3D absorbed dose to organs or lesions with volumes smaller than 100 mL. Image based 3D dosimetry for 177Lu-DOTATOC PRRT is significantly affected by the type of algorithm used to register sequential SPECT/CT scans.

AB - Peptide receptor radionuclide therapy (PRRT) is an effective MRT (molecular radiotherapy) treatment, which consists of multiple administrations of a radiopharmaceutical labelled with 177Lu or 90Y. Through sequential functional imaging a patient specific 3D dosimetry can be derived. Multiple scans should be previously co-registered to allow accurate absorbed dose calculations. The purpose of this study is to evaluate the impact of image registration algorithms on 3D absorbed dose calculation. A cohort of patients was extracted from the database of a clinical trial in PRRT. They were administered with a single administration of 177Lu-DOTATOC. All patients underwent 5 SPECT/CT sequential scans at 1 h, 4 h, 24 h, 40 h, 70 h post-injection that were subsequently registered using rigid and deformable algorithms. A similarity index was calculated to compare rigid and deformable registration algorithms. 3D absorbed dose calculation was carried out with the Raydose Monte Carlo code. The similarity analysis demonstrated the superiority of the deformable registrations (p <.001). Average absorbed dose to the kidneys calculated using rigid image registration was consistently lower than the average absorbed dose calculated using the deformable algorithm (90% of cases), with percentage differences in the range [−19; +4]%. Absorbed dose to lesions were also consistently lower (90% of cases) when calculated with rigid image registration with absorbed dose differences in the range [−67.2; 100.7]%. Deformable image registration had a significant role in calculating 3D absorbed dose to organs or lesions with volumes smaller than 100 mL. Image based 3D dosimetry for 177Lu-DOTATOC PRRT is significantly affected by the type of algorithm used to register sequential SPECT/CT scans.

KW - Deformable image registration

KW - Dose calculation

KW - Dosimetry

KW - PRRT

UR - http://www.scopus.com/inward/record.url?scp=85042094627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042094627&partnerID=8YFLogxK

U2 - 10.1016/j.ejmp.2017.11.021

DO - 10.1016/j.ejmp.2017.11.021

M3 - Article

AN - SCOPUS:85042094627

VL - 45

SP - 177

EP - 185

JO - Physica Medica

JF - Physica Medica

SN - 1120-1797

ER -